A股異動 | 鵬鼎控股漲7% 2022年Q1淨利預增65%-75%
格隆匯4月7日丨鵬鼎控股(002938.SZ)盤中漲7.68%,報29.99元,總市值696億元。鵬鼎控股4月6日發佈業績預吿,預計2022年一季度歸母淨利5.79億元-6.14億元,同比增長65%-75%。報吿期內,公司持續進行成本管控、製程改善、強化自動化生產,降低生產成本,利潤增加。報吿期內,利潤成長主要來自MINILED及MSAP等產品,公司充分利用業已形成的技術能力、工藝能力及管理能力,使產線良率穩步提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.